Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Philippines and Malaysian regulatory agencies approve Celsion’s Phase III Thermodox trial

Celsion Corporation announced today that it has received approval from the regulatory agencis in the Philippines and Malaysia for its Pivotal Phase III primary liver cancer Clinical Trial Application.

19 Oct 2009

Lubricin injections can reduce cartilage degeneration

Medical researchers will report findings today (Oct. 19) that demonstrate that injecting the protein lubricin into knee joints can dramatically reduce cartilage degeneration.

19 Oct 2009

Physical therapists can promote early diagnosis of breast cancer-related lymphedema

As breast cancer awareness month is observed during October, the American Physical Therapy Association (APTA) is hoping to shine a spotlight on lymphedema, a chronic, debilitating and often irreversible side effect of cancer treatment.

19 Oct 2009

Institute Curie Hospital in France adds another TomoTherapy radiation therapy system

TomoTherapy Incorporated announced today that the Institute Curie Hospital in France has purchased a second TomoTherapy® radiation therapy system, to support the increasing demand for intensity-modulated radiation therapy (IMRT). The Institute Curie Hospital has been treating cancer patients with TomoTherapy technology since March 2007, when it became the first hospital in France to adopt the technology.

19 Oct 2009

Genes to determine which rectal cancer patient can avoid surgical procedure for treatment

A set of 87 genes one day may be used to routinely determine which patients can be successfully treated for advanced rectal cancer without undergoing a surgical procedure, researchers announced at the 2009 Clinical Congress of the American College of Surgeons.

15 Oct 2009

NICoE to study how brain works after sustaining combat-related injury using Elekta Neuromag

Projected to open in mid 2010, the National Intrepid Center of Excellence (NICoE) is a facility dedicated to the study and care of military personnel and veterans suffering from traumatic brain injury (TBI) and psychological health issues. Using Elekta Neuromag®, an advanced magnetoencephalography (MEG) device, NICoE plans to shed light on how the brain works after sustaining combat-related injury.

From Elekta 15 Oct 2009

New relocatable radiation therapy system from TomoTherapy

TomoTherapy Incorporated announced today the availability of the industry's first relocatable radiation therapy solution -- TomoMobile™ -- which is designed to quickly and cost-effectively bring cutting-edge radiation therapy solutions to patients in underserved and rural markets.

15 Oct 2009

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Clinical experience with the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi-disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.

12 Oct 2009

TomoTherapy to present an update on TomoTherapy radiation therapy platform

TomoTherapy Incorporated announced today that it will host an analyst and investor presentation in conjunction with the annual ASTRO (American Society for Radiation Oncology) meeting on Monday, Nov. 2, 2009, at 8:00 a.m. CT.

12 Oct 2009

HealthHelp to provide radiation oncology management on national scale

With cancer’s incidence and treatment costs rising, HealthHelp has become the first company to provide radiation oncology management on a national scale. Approximately 4 million Humana patients in 46 states will benefit from this innovative new program.

9 Oct 2009

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today shared a recent announcement regarding progress in the development of a proton therapy center at Todd Cancer Institute at Long Beach Memorial Medical Center.

8 Oct 2009

Government handout of samples of potassium iodide helps to boost sales for Nukepills.com

The recent localized government handout of samples of potassium iodide has sky-rocketed sales for online merchant Nukepills.com. Recent retail orders of Iosat(TM) Potassium Iodide have increased by almost 400% and wholesale orders to vendors and medical facilities have surged as well for the authorized national distributor.

7 Oct 2009

Helix BioPharma's pre-IND meetings with the FDA for Topical Interferon Alpha-2b and L-DOS47 fruitful

Helix BioPharma Corp. today announced progress updates for its ongoing Topical Interferon Alpha-2b and L-DOS47 product development programs following pre-investigational new drug ("pre-IND") meetings with the U.S. Food and Drug Administration ("FDA").

7 Oct 2009

Stereotactic Radiosurgery for metastatic brain tumors reduces risks of learning and memory problems

Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than those treated with SRS alone, according to researchers at The University of Texas M. D. Anderson Cancer Center.

7 Oct 2009

Aeolus Pharmaceuticals raises $1.65 million from existing institutional shareholders

Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing, Aeolus received $1.65 million in gross proceeds in exchange for 5,892,857 Units (the “Units”), with each Unit comprised of one share of Aeolus Pharmaceuticals common stock, and a seven year warrant to purchase up to two additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.28 per share, for a per Unit purchase price of $0.28.

7 Oct 2009

New fruit-flavored protein drinks for nutritionally challenged

The Isopure Company, LLC. announced today the U.S. launch of Isopure Plus - a new line of clear, fruit-flavored protein drinks offering seniors and people with nutritional challenges a great-tasting, easy-to-digest alternative to thick milkshake-like protein formulations.

6 Oct 2009

Elekta Impac Software to demonstrate its integrated oncology EHR, MOSAIQ at EHR Symposium

Elekta Impac Software has been selected to demonstrate at the 2009 American Society of Clinical Oncology (ASCO) Electronic Health Records (EHR) Symposium: Harnessing the EHR, From Incentives to Sustainability, October 6-7, in San Francisco, California.

From Elekta 6 Oct 2009

Two-thirds of tonsil tumour samples show evidence of HPV-16 gene: Study

It is estimated that more than 7,000 people are diagnosed with head and neck cancer each year in the UK and approximately 3,500 cases result in death. These cancers include tumours of the mouth, lips, throat and voice-box, and some have been linked to the sexually transmitted infection, HPV-16. Scientists at Liverpool analysed the DNA of more than 90 cancerous tissue samples to look for genes that indicated infection.

6 Oct 2009

Study identifies new genes associated with head and neck cancer

A Henry Ford Hospital study has identified 231 new genes associated with head and neck cancer, one of the most deadly cancers responsible for 2.1 percent of all cancer deaths in the United States.

5 Oct 2009

Few risks to babies born to parents who underwent cancer treatment in childhood: Study

Whether they can have children is one of the major concerns for adult survivors of childhood and adolescent cancer because fertility can be compromised by cancer treatment. For cancer survivors who can have children, two new studies led by researchers at Fred Hutchinson Cancer Research Center may help alleviate fears that their childhood disease will adversely impact their newborns.

3 Oct 2009

Radiation Therapy News and Research

Further Reading

Philippines and Malaysian regulatory agencies approve Celsion’s Phase III Thermodox trial

Lubricin injections can reduce cartilage degeneration

Physical therapists can promote early diagnosis of breast cancer-related lymphedema

Institute Curie Hospital in France adds another TomoTherapy radiation therapy system

Genes to determine which rectal cancer patient can avoid surgical procedure for treatment

NICoE to study how brain works after sustaining combat-related injury using Elekta Neuromag

New relocatable radiation therapy system from TomoTherapy

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

TomoTherapy to present an update on TomoTherapy radiation therapy platform

HealthHelp to provide radiation oncology management on national scale

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

Government handout of samples of potassium iodide helps to boost sales for Nukepills.com

Helix BioPharma's pre-IND meetings with the FDA for Topical Interferon Alpha-2b and L-DOS47 fruitful

Stereotactic Radiosurgery for metastatic brain tumors reduces risks of learning and memory problems

Aeolus Pharmaceuticals raises $1.65 million from existing institutional shareholders

New fruit-flavored protein drinks for nutritionally challenged

Elekta Impac Software to demonstrate its integrated oncology EHR, MOSAIQ at EHR Symposium

Two-thirds of tonsil tumour samples show evidence of HPV-16 gene: Study

Study identifies new genes associated with head and neck cancer

Few risks to babies born to parents who underwent cancer treatment in childhood: Study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News